" So, yes, LATCH is CytoDyn’s first explicit ste
Post# of 151802
(Total Views: 558)
Posted On: 02/22/2025 3:10:30 PM
" So, yes, LATCH is CytoDyn’s first explicit step into testing Leronlimab as a cure in humans, likely a Phase I or I/II trial given its exploratory nature."
The LATCH protocols should have been submitted around 1st week of Jan..
Colorectal cancer Interim will be our 1st data.
Also Alzheimer’s
I can't see GF being interested on Latch.
Maybe some data cross cutting I guess.
Just not full ownership, etc....
Buy we're close to so much...of alot.
Yes sir !!
The LATCH protocols should have been submitted around 1st week of Jan..
Colorectal cancer Interim will be our 1st data.
Also Alzheimer’s
I can't see GF being interested on Latch.
Maybe some data cross cutting I guess.
Just not full ownership, etc....
Buy we're close to so much...of alot.
Yes sir !!
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼